324 related articles for article (PubMed ID: 23872728)
1. Use of mastoid obliteration techniques in cholesteatoma.
Yung M; Bennett A
Curr Opin Otolaryngol Head Neck Surg; 2013 Oct; 21(5):455-60. PubMed ID: 23872728
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow up after bony mastoid and epitympanic obliteration: radiological findings.
Vercruysse JP; De Foer B; Somers T; Casselman J; Offeciers E
J Laryngol Otol; 2010 Jan; 124(1):37-43. PubMed ID: 19775491
[TBL] [Abstract][Full Text] [Related]
3. Long-term Results of Troublesome CWD Cavity Reconstruction by Mastoid and Epitympanic Bony Obliteration (CWR-BOT) in Adults.
Vercruysse JP; van Dinther JJ; De Foer B; Casselman J; Somers T; Zarowski A; Cremers CC; Offeciers E
Otol Neurotol; 2016 Jul; 37(6):698-703. PubMed ID: 27023012
[TBL] [Abstract][Full Text] [Related]
4. A technique for concurrent procedure of mastoid obliteration and meatoplasty after canal wall down mastoidectomy.
Kim CW; Oh JI; Choi KY; Park SM; Park MI
Auris Nasus Larynx; 2012 Dec; 39(6):557-61. PubMed ID: 22321811
[TBL] [Abstract][Full Text] [Related]
5. Canal wall-down mastoidectomy with mastoid obliteration for pediatric cholesteatoma.
Sun J; Sun J; Hu Y; Lv Q; Wang Y; Li X; Xu W; Wang S; Mei Z; Wan G
Acta Otolaryngol; 2010 Feb; 130(2):259-62. PubMed ID: 19565369
[TBL] [Abstract][Full Text] [Related]
6. Canal wall up surgery with mastoid and epitympanic obliteration in acquired cholesteatoma.
Hellingman CA; Geerse S; de Wolf MJF; Ebbens FA; van Spronsen E
Laryngoscope; 2019 Apr; 129(4):981-985. PubMed ID: 30408197
[TBL] [Abstract][Full Text] [Related]
7. Mastoid and epitympanic bony obliteration in pediatric cholesteatoma.
Vercruysse JP; De Foer B; Somers T; Casselman JW; Offeciers E
Otol Neurotol; 2008 Oct; 29(7):953-60. PubMed ID: 18719515
[TBL] [Abstract][Full Text] [Related]
8. Non-EPI DW MRI in planning the surgical approach to primary and recurrent cholesteatoma.
Migirov L; Wolf M; Greenberg G; Eyal A
Otol Neurotol; 2014 Jan; 35(1):121-5. PubMed ID: 24317217
[TBL] [Abstract][Full Text] [Related]
9. Tolerance and safety of 45S5 bioactive glass used in obliteration procedures during middle ear surgery: Preliminary results.
Al Tamami N; Bawazeer N; Fieux M; Zaouche S; Tringali S
Am J Otolaryngol; 2020; 41(6):102542. PubMed ID: 32620365
[TBL] [Abstract][Full Text] [Related]
10. Successful obliteration of troublesome and chronically draining cavities.
Geerse S; Ebbens FA; de Wolf MJ; van Spronsen E
J Laryngol Otol; 2017 Feb; 131(2):138-143. PubMed ID: 28069077
[TBL] [Abstract][Full Text] [Related]
11. Management of cholesteatoma: status of the canal wall.
Syms MJ; Luxford WM
Laryngoscope; 2003 Mar; 113(3):443-8. PubMed ID: 12616194
[TBL] [Abstract][Full Text] [Related]
12. Mastoid obliteration: autogenous cranial bone pAte reconstruction.
Roberson JB; Mason TP; Stidham KR
Otol Neurotol; 2003 Mar; 24(2):132-40. PubMed ID: 12621322
[TBL] [Abstract][Full Text] [Related]
13. Alternative to canal wall-down mastoidectomy for sclerotic mastoid cavities: epitympanoplasty with mastoid obliteration.
Heo KW; Kang MK; Park JY
Ann Otol Rhinol Laryngol; 2014 Jan; 123(1):47-52. PubMed ID: 24574423
[TBL] [Abstract][Full Text] [Related]
14. Partial mastoid obliteration combined with soft-wall reconstruction for middle ear cholesteatoma.
Suzuki H; Ikezaki S; Imazato K; Koizumi H; Ohbuchi T; Hohchi N; Hashida K
Ann Otol Rhinol Laryngol; 2014 Aug; 123(8):571-5. PubMed ID: 24634153
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic Management of Primary Acquired Cholesteatoma.
Chiao W; Chieffe D; Fina M
Otolaryngol Clin North Am; 2021 Feb; 54(1):129-145. PubMed ID: 33131767
[TBL] [Abstract][Full Text] [Related]
16. Value of high-resolution computed tomography and magnetic resonance imaging in the detection of residual cholesteatomas in primary bony obliterated mastoids.
De Foer B; Vercruysse JP; Pouillon M; Somers T; Casselman JW; Offeciers E
Am J Otolaryngol; 2007; 28(4):230-4. PubMed ID: 17606036
[TBL] [Abstract][Full Text] [Related]
17. Which technique is better for cholesteatoma surgery?
Deniz M; Uslu C; Koldaş C; Deniz B
B-ENT; 2015; 11(2):109-15. PubMed ID: 26563010
[TBL] [Abstract][Full Text] [Related]
18. Canal wall reconstruction in cholesteatoma surgeries: rate of residual.
Roux A; Bakhos D; Lescanne E; Cottier JP; Robier A
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):2791-7. PubMed ID: 25227760
[TBL] [Abstract][Full Text] [Related]
19. Mastoid obliteration with hydroxyapatite--the value of high resolution CT scanning in detecting recurrent cholesteatoma.
Yung MM; Karia KR
Clin Otolaryngol Allied Sci; 1997 Dec; 22(6):553-7. PubMed ID: 9466070
[TBL] [Abstract][Full Text] [Related]
20. Canal wall reconstruction tympanomastoidectomy with mastoid obliteration.
Gantz BJ; Wilkinson EP; Hansen MR
Laryngoscope; 2005 Oct; 115(10):1734-40. PubMed ID: 16222186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
